Nu Skin Enterprises (NUS) Restates Q1 Financials Following Audit Committee Determination
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
JPMorgan Downgrades Nu Skin Enterprises (NUS) to Neutral
August 7, 2014 6:47 AM EDTJPMorgan downgraded Nu Skin Enterprises (NYSE: NUS) from Overweight to Neutral with a price target of $50.00 (from $100.00).
For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.
Shares of Nu Skin Enterprises closed at $46.52 yesterday.
... MoreNu Skin Enterprises (NUS) Slammed on Q2 'Miss', Q3 Warning
August 6, 2014 8:15 AM EDTNu Skin Enterprises (NYSE: NUS) is down a quick 15% on disappointing Q2 results and outlook. Peers are also on watch: Herbalife Ltd. (NYSE: HLF) (-1.7%) and USANA Health Sciences Inc. (NYSE: USNA).
... More
Nu Skin Enterprises Inc. (NUS) Misses Q2 EPS by 14c; Warns for Q3
August 6, 2014 7:32 AM EDTNu Skin Enterprises Inc. (NYSE: NUS) reported Q2 EPS of $1.13, $0.14 worse than the analyst estimate of $1.27. Revenue for the quarter came in at $650 million versus the consensus estimate of $709.03 million.
Nu Skin Enterprises Inc. sees Q3 2014 EPS of $0.90-$0.95, versus the consensus of $1.68. Nu Skin Enterprises Inc. sees Q3 2014... More
